Archives

Law: People are not Cows and Off-label Prescribing is Utterly Different – RECORDED WEBINAR

The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

This year's sympoisum had an overall topic of Veterinary Medicines.

Learning Objectives

The activity met the following learning objectives for Pharmacists:
  • Discuss the characteristics and trends in off label prescribing.
  • Distinguish between off label prescribing for people and animals.
  • Describe the FDA’s authority to regulate off label prescribing

Activity Release Dates

Released:  April 25, 2024
Expires:  April 25, 2027

Course Fee

$17 Pharmacist

ACPE UAN Codes

 0009-0000-24-018-H03-P

Session Code

24RS18-ABC28

Accreditation Hours

1.0 hours of CE

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-24-018-H03-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

Gerald Gianutsos, PhD, JD
Professor Emeritus
University of Connecticut School of Pharmacy
Storrs, CT             

Faculty Disclosure

  • Gerry Gianutsos doesn't have any relationships with ineligible companies.

 

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

Post Test Pharmacist

1. Off label drug uses generally do not become on-label uses. What is a primary reason for this?
A. There is a financial disincentive to manufacturers.
B. The FDA has no easy mechanism to accomplish this.
C. Manufacturers want to emphasize their drug’s primary.

2. You have a sick cow. Which of the following is correct about the type of drug that can be used for treatment?
A. Any drug approved by the FDA for human use.
B. A drug approved for use in chickens if there is no comparable drug approved for cows.
C. A drug that can be compounded by a pharmacist and added to the cow's feed.

3. What category of drugs has the highest rate of off-label use? (Prior to the pandemic.)
A. Anti-seizure drugs
B. Anti-depressants
C. Antibiotics
4. Why does the FDA take a hands-off approach to off-label use?
A. The FDA is not permitted to prevent manufacturers from touting an unapproved use once a drug has been approved.
B. The FDA does not regulate the practice of medicine.
C. The FDA can only act after it receives information of unintended consequences from off-label use.

5. When may a pharmacist recommend an OTC human drug for an animal?
A. Under any circumstances so long as it is not a food animal.
B. When there is no comparable veterinary product available.
C. A pharmacist may not recommend a human OTC drug for use in an animal.

6. Which of the following is a notable risk associated with illicit use of xylazine?
A. Naloxone-resistant overdose
B. Whole body rash and desquamation
C. Respiratory depression

7. The FDA was sued for publishing a warning about the off-label use of ivermectin for COVID. What was the basis of the lawsuit?
A. The FDA cannot prevent physicians from prescribing a drug off-label and need not issue warnings.
B. The FDA's warning on ivermectin was erroneous and used misplaced humor to try to sway opinions.
C. In publishing warning overstepped the FDA’s authority and interfered with the doctor-patient relationship.

Compounding: Go Hog Wild: Creative (and Informed) Veterinary Compounding – RECORDED WEBINAR

The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

This year's sympoisum had an overall topic of Veterinary Medicines.

Learning Objectives

  • Examine veterinary pharmacy challenges, including species-specific pharmacokinetics, patient adherence, drug availability, and contraindications

 
  • Discuss key compounding principles, including the benefits and risks of different routes of administration, excipients, and flavoring agents.
  • List labeling requirements for veterinary compounds

Activity Release Dates

Released:  April 25, 2024
Expires:  April 25, 2027

Course Fee

$17 Pharmacist

ACPE UAN Codes

 0009-0000-24-019-H07-P

Session Code

24RS19-CBA96

Accreditation Hours

1.0 hours of CE

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-24-019-H07-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

Laura Nolan, CPhT, CSPT
Pharmacy Lab Coordinator
University of Connecticut School of Pharmacy
Storrs, CT     

Faculty Disclosure

  • Laura Nolan doesn't have any relationships with ineligible companies.

 

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

Post Test Pharmacist

    1. Farmer Brown's large Maine Coon cat needs fluoxetine. Considering size, anatomy, and skin absorption, which animal would require a similar dose of fluoxetine transdermal gel?
    A . A small terrier dog
    B. A medium sized sphinx (hairless) cat
    C. A large barn owl

    2. Meow-Meow is a domestic American cat. She weighs 6.3 pounds, although she needs to gain at least 3 pounds. She needs medication for her heart condition, and the veterinarian wants to prescribe lisinopril 0.25 mg/kg once daily. YIKES! You calculate that Meow-Meow weighs 2.9 kg and needs a dose of 0.725 mg of lisinopril. Can you compound this dose?
    A. No, the veterinarian needs to find a different medication
    B. Yes, but it would be easier to give 1.5 mg every other day
    C. Yes, because a commercial product is unavailable in this strength

    3. Your 30-pound hound, Bosco, is begging to eat the food you left on your plate after dinner. In keeping with your house rule never to feed the dog from the table, you take your plate to the sink and get Bosco’s bowl. Which of the following things should you throw in the trash rather than feed to Bosco?
    A. The piece of grilled, boned ribeye steak
    B. The grapes and raisins on the salad
    C. The plain baked potato with yogurt

    4. Your client, Venice Marriot, needs to have a medication compounded for her teacup chihuahua Tokyo. She indicates that she and Tokyo prefer medications that are pink. After discussing the pros and cons of compounding with color, which food coloring should you use to make a pink oral solution?
    A. Natural beet extract
    B. FD&C Red No. 3
    C. Neither

    5. Which of these basic oral paste formulas would be best to use for Farmer Brown’s cat?
    Ingredient Formula 1 Formula 2 Formula 3
    Polyethylene glycol 300 65 grams 25 grams
    Polyethylene glycol 3350 35 grams 25 grams 25 grams
    Propylene glycol 50 grams 25 grams
    Molasses (for horses) 50 grams

    A. Formula 1
    B. Formula 2
    C. Formula 3

    6. Which flavoring would be best suited for a picky Emperor penguin at Mystic Aquarium?
    A. Orange or mango flavoring
    B. Sardine or tuna flavors
    C. Beef or liver flavoring

    7. What Is the BEST way to improve pharmacy personnel’s knowledge of veterinary medications?
    A. Pharmacies can be sure to have a veterinary drug handbook at the pharmacy and that the computer system flags veterinary precautions.
    B. Pharmacists can complete a continuing education activity on veterinary pharmacy and require all other staff members to take it also.
    C. Pharmacy owners and systems can take out extra liability insurance and pray that nothing happens to any animal that receives a prescription from their pharmacies.

    Patient Safety: Teaching Old Dogs New Tricks: Dispensing for Companion Animals in Community Pharmacy – RECORDED WEBINAR

    The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

    This year's sympoisum had an overall topic of Veterinary Medicines.

    Learning Objectives

    • Describe the types of animals and health problems most likely to be encountered in community pharmacies
    • List the most common prescriptions for companion animals and key dispensing considerations
    • Identify reliable resources when filling prescriptions for animals

    Activity Release Dates

    Released:  April 25, 2024
    Expires:  April 25, 2027

    Course Fee

    $17 Pharmacist

    ACPE UAN Codes

     0009-0000-24-020-H05-P

    Session Code

    24RS20-TXJ88

    Accreditation Hours

    1.0 hours of CE

    Accreditation Statement

    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-24-020-H05-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

    Grant Funding

    There is no grant funding for this activity.

    Faculty

    Isabella Bean, PharmD, FSVHP
    Staff Pharmacist
    Encompass Health Rehab Center
    Sioux Falls, SD

    Faculty Disclosure

    • Isabella Bean doesn't have any relationships with ineligible companies.

     

    Disclaimer

    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

    Content

    Post Test Pharmacist

    The Human-Animal Bond: How Close Is Too Close? – RECORDED WEBINAR

    The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

    This year's sympoisum had an overall topic of Veterinary Medicines.

    Learning Objectives

    • Recognize and describe different zoonotic diseases: Rabies, Lyme Disease, Ringworm (Dermatophytosis), Leptospirosis, Giardia, and Toxoplasmosis

     
    • Describe method of transmission of each disease
    • List the treatment of each disease (if possible)
    • Indicate the species of animal that can harbor the disease
    • Describe how to prevent the disease

    Activity Release Dates

    Released:  April 25, 2024
    Expires:  April 25, 2027

    Course Fee

    $17 Pharmacist

    ACPE UAN Codes

     0009-0000-24-021-H01-P

    Session Code

    24RS21-VXK92

    Accreditation Hours

    1.0 hours of CE

    Accreditation Statement

    The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-24-021-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

    Grant Funding

    There is no grant funding for this activity.

    Faculty

    Sarah Plante, DVM
    Associate Veterinarian
    Fenton River Veterinary Hospital
    Tolland, CT

    Faculty Disclosure

    • Sarah Plante doesn't have any relationships with ineligible companies.

     

    Disclaimer

    The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

    Content

    Post Test Pharmacist

    The Human-Animal Bond: How Close is Too Close? 

     

    • Recognize and describe different zoonotic diseases: Rabies, Lyme Disease, Ringworm (Dermatophytosis), Leptospirosis, Giardia, and Toxoplasmosis
    • Describe method of transmission of each disease
    • List the treatment of each disease (if possible)
    • Indicate the species of animal that can harbor the disease
    • Describe how to prevent the disease

     

       
      1. At what age is the earliest a dog or cat can receive the rabies vaccination?
      A. 8 weeks
      B. 6 months
      C. 12 weeks

      2. What is the symptom of Lyme Disease in dogs that owners tend to notice first?
      A. Shifting lameness
      B. Vomiting
      C. Increased thirst and urination (PUPD)

      3. What is the best way to prevent most zoonotic infections?
      A. Avoid wildlife
      B. Use essential oils
      C. Wash your hands

      4. What antibiotic do veterinarians use most often to treat Spirochete bacterial infections?
      A. Doxycycline
      B. Clindamycin
      C. Amoxicillin-clavulanic Acid

      5. How are most zoonotic intestinal parasites are spread?
      A. Aerosolized
      B. Infection through break in the skin
      C. Fecal-oral

      6. What zoonotic disease causes an itchy, circular red lesion on the skin?
      A. Lyme disease
      B. Ringworm
      C. Leptospirosis

      7. What species most commonly carries toxoplasma?
      A . Cats
      B. Dogs
      C. Ferrets

      Animal Models of Disease: Barking up the Right Tree – RECORDED WEBINAR

      The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

      This year's sympoisum had an overall topic of Veterinary Medicines.

      Learning Objectives

      • Discuss current legal and ethical positions on the use of animals in research
      • List the pros and cons of various animal models
      • Recall advantages and disadvantages for each animal model

      Activity Release Dates

      Released:  April 25, 2024
      Expires:  April 25, 2027

      Course Fee

      $17 Pharmacist

      ACPE UAN Codes

       0009-0000-24-022-H01-P

      Session Code

      24RS22-KVX29

      Accreditation Hours

      1.0 hours of CE

      Accreditation Statement

      The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-24-022-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

      Grant Funding

      There is no grant funding for this activity.

      Faculty

      Jeannette Y. Wick, RPh, MBA
      Director OPPD
      UConn School of Pharmacy
      Storrs, CT

      Faculty Disclosure

      • Jeannette Wick doesn't have any relationships with ineligible companies.

       

      Disclaimer

      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

      Content

      Post Test Pharmacist

      Evidence Based LDL Lowering Options-RECORDED WEBINAR

      The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

      This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective.  This presentation deals with secondary cancers resulting from primary cancer treatment.

      Learning Objectives

      The activity met the following learning objectives for Pharmacists:
      ·    Describe the role of dietary modification for LDL modification

       
      ·       Identify how some dietary supplement ingredients mimic the mechanisms of action of prescription drugs
      ·       Describe the magnitude of plant sterols and stanols, red yeast rice, silybum M, berberine, cinnamon, green tea extract, and garlic LDL reduction as monotherapy
      ·       Describe the potential for combination therapy to increase the magnitude of benefit
      ·       Compare and contrast with prescription LDL lowering options
      ·  Describe risks of contamination and adulteration with dietary supplements

      Activity Release Dates

      Released:  April 27, 2023
      Expires:  April 27, 2026

      Course Fee

      $17 Pharmacist

      ACPE UAN Codes

       0009-0000-23-010-H01-P

      Session Code

      23RW10-CBA96

      Accreditation Hours

      1.0 hours of CE

      Accreditation Statement

      The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-23-010-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

      Grant Funding

      There is no grant funding for this activity.

      Faculty

      C. Michael White, PharmD, FCCP, FCP
      Professor and Department Head Pharmacy Practice
      University of Connecticut School of Pharmacy and Director HOPES Research Group
      Storrs, CT

      Faculty Disclosure

      Dr. White is a co-investigator on a project assessing the risk of bias for an anti-bleeding drug, andexanet alfa. This is a bleeding reversal agent and AstraZeneca is funding it. They do not have a lipid reducing product that I am discussing in this presentation or as a competitor to the products I am discussing.  nonetheless.

      Disclaimer

      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

      Content

      Post Test Pharmacist

      1. Which of the following fats has the worst effects on the LDL to HDL ratio?
      2. Trans fats
      3. Saturated fats
      4. MUFAs

       

      1. Which of the following describes the impact of the Mediterranean diet on patients?
      2. It reduces cardiovascular events significantly and LDL by a large amount
      3. It reduces cardiovascular events significantly and LDL to a modest amount
      4. It reduces the need for lipid lowering therapy by a large amount

       

      1. Which of the following supplements is linked correctly to its likely mechanism of action?
      2. Berberine – Blocks the enzyme HMG CoA Reductase
      3. Red Yeast Rice – Blocks formation of the protein PCSK9
      4. Sterols/Stanols – Block LDL reabsorption and fat absorption

       

      1. Tobias Whale is a 50-year-old super villain in the series Black Lightening. In addition to killing the innocent and extorting small business owners, he also has a poor baseline diet. He requires a 6% reduction in his LDL to reach his goal. Which of the following natural products are MOST LIKELY to get him to goal?
      2. Cinnamon
      3. Green tea
      4. Red Yeast Rice

       

      1. What does a USP or NSF seal on a bottle of Red Yeast Rice tell you?
      2. That the product will reduce your LDL by 30% under normal circumstances
      3. That the product will reduce your risk of ASCVD events
      4. That the specified active ingredient is actually in the pills

       

      “I don’t dig your cig” : Strategies for tobacco cessation-RECORDED WEBINAR

      The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

      This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective.  This presentation deals with secondary cancers resulting from primary cancer treatment.

      Learning Objectives

      ·  Recall the medicinal uses of tobacco
      ·  Describe the cycle of tobacco addition
      ·  Identify strategies for counseling patients on behavioral techniques recommended for tobacco cessation
      ·   Compare the safety and efficacy of FDA approved pharmacotherapies for tobacco cessation
      ·    Discuss recommendations from national practice guidelines for tobacco cessation and apply them to a patient case

      Activity Release Dates

      Released:  April 27, 2023
      Expires:  April 27, 2026

      Course Fee

      $17 Pharmacist

      ACPE UAN Codes

       0009-0000-23-012-H01-P

      Session Code

      23RW12-VXK92

      Accreditation Hours

      1.0 hours of CE

      Accreditation Statement

      The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-23-011-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

      Grant Funding

      There is no grant funding for this activity.

      Faculty

      Stefanie Nigro, PharmD, BCACP, CDCES,
      Associate Clinical Professor
      Department of Pharmacy Practice
      University of Connecticut School of Pharmacy
      Storrs, CT

      Faculty Disclosure

      Dr. Nigro has no financial relationship with inelegible companies

      Disclaimer

      The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

      Content

      Post Test Pharmacist

        1. Which patient characteristic supports initiation of combination therapy for smoking cessation?
          1. Age younger than 65 years
          2. Elevated eosinophil levels
          3. Heavy smoker with high dependence

         

        1. When should patients begin varenicline relative to their quit date if they are following an approach with a traditional fixed quit date?
          1. 1 week prior
          2. 3 days prior
          3. The same day

         

        1. Which of the following treatments for smoking cessation requires a dose adjustment for renal impairment?
          1. Nicotine lozenge
          2. Bupropion SR
          3. Varenicline

         

        1. Which of the following combinations is the most effective for smoking cessation?
        2. Combination NRT
        3. Bupropion SR + nicotine patch
        4. Varenicline + nicotine patch

         

        1. Which statement correctly describes the comparative efficacy of first-line smoking cessation monotherapies?
        2. Bupropion SR is more effective than NRT
        3. All NRTs are more effective than varenicline
        4. Varenicline is more effective than NRT or bupropion SR

         

        1. Why can’t women who are younger than 35 who smoke 15 or more cigarettes per day use estrogen containing contraceptives?
        2. A pharmacokinetic drug interaction decreases contraceptive efficacy and increases risk for adverse effects
        3. A pharmacodynamic drug interaction increases risk of venous thromboembolism, myocardial infarction and stroke
        4. A pharmacokinetic drug interaction increases estrogen levels and also magnifies estrogen-like side effects

         

        1. Patients should be counseled to avoid eating or drinking 15 minutes prior to the use of which therapies?
        2. Nicotine lozenge, gum and inhaler
        3. Nicotine lozenge and gum
        4. Nicotine nasal spray, gum and lozenge

         

         

        1. Which of the following smoking cessation therapies does NOT match with the listed side effect?
        2. Nicotine gum and vivid dreams
        3. Nicotine nasal spray and nasal irritation
        4. Bupropion SR and tremor

         

         

        1. Chad is a 55-year-old male patient with a past medical history including diabetes mellitus type 2, hyperlipidemia, hypertension, and chronic obstructive pulmonary disease. He is currently hospitalized due to a myocardial infarction but is now stable Chad recognizes that quitting smoking is critical to his cardiovascular health and wants to try to quit. Which of the following therapies is a first-line recommendation for Chad to initiate while hospitalized, according to the American College of Cardiology?  

         

        1. Pharmacotherapy is contraindicated 2 weeks post myocardial infarction
        2. Combination therapy with Chantix and NRT
        3. Combination NRT

         

         

        1. Melissa is a 34-year-old female who has smoked two packs per day since she was 19 years old. She comes to the pharmacy and asks if there is a medication that can help her feel ‘readier’ to quit. She does not feel ready to set a quit date but wants to try and work toward this goal. Which of the following medications can Melissa start now with a goal of reducing smoking?
        2. Chantix or NRT
        3. Any of the first-line medications
        4. Bupropion SR

         

         

        Honey: A Sweet Solution?-RECORDED WEBINAR

        The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

        This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective.  This presentation deals with secondary cancers resulting from primary cancer treatment.

        Learning Objectives

        • Describe Medicinal History of Honey
        • List Composition and Properties of Honey
        • Identify Diseases and Conditions Treated with Honey
        • Recognize Biologic Activities of Honey

        Activity Release Dates

        Released:  April 27, 2023
        Expires:  April 27, 2026

        Course Fee

        $17 Pharmacist

        ACPE UAN Codes

         0009-0000-23-013-H01-P

        Session Code

        23RW13-KVX29

        Accreditation Hours

        1.0 hours of CE

        Accreditation Statement

        The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

        Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-23-013-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

        Grant Funding

        There is no grant funding for this activity.

        Faculty

        Andrea Hubbard, PhD
        Professor Emeritus
        University of Connecticut School of Pharmacy
        Storrs, CT

        Faculty Disclosure

        Dr. Hubbard has no financial relationship with inelegible companies

        Disclaimer

        The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

        Content

        Post Test Pharmacist

            HONEY: A SWEET SOLUTION? Dr. Andrea K. Hubbard

             

            Which of the following is correct?

            1. Propolis helps in the maturation of the queen bee.
            2. Royal jelly helps in the development of the king bee.
            3. Honeybees collect nectar and pollen in separate flights.

             

            How have various people used honey or products of bees for centuries?

            1. Treatment of infected wounds
            2. Element in marriage ritual
            3. Food for livestock

             

             

            What component of honey creates its low pH and antimicrobial activity?

            1. Potassium
            2. Dextrose
            3. Gluconic acid

             

            At what age is it safe to give children honey?

            1. Younger than 1 year of age
            2. Older than 2 years of age
            3. Once they are weaned

             

            Which of the following apitherapy has the FDA-approved?

            1. Propolis
            2. Royal jelly
            3. Honey

             

            Which of the following is a function in honey that is associated with hydrogen peroxide and methylglyoxal?

            1. Vitamin
            2. Mineral
            3. Oxidant

             

            Fill in the blank: Bees lower the water content in honey to _____ through enzymes in their crop, fanning their wings, and keeping their hive at a high temperature.

            1. 25%
            2. 18%
            3. 7%

             

            Ayahuasca and Drug Interaction: The Good, the Bad, the Soul-RECORDED WEBINAR

            The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

            This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective.  This presentation deals with secondary cancers resulting from primary cancer treatment.

            Learning Objectives

            The activity met the following learning objectives for Pharmacists:
            ·  Describe pharmacological properties of harmala alkaloids in ayahuasca
            ·  Define adverse reactions associated with food and dietary interactions with ayahuasca such as hypertensive crisis and serotonin toxicity
            ·  Construct management strategies to avoid adverse reactions from interacting foods and drugs
            ·  Discuss observational, clinical, and toxicologic studies relating to ayahuasca use

            Activity Release Dates

            Released:  April 27, 2023
            Expires:  April 27, 2026

            Course Fee

            $17 Pharmacist

            ACPE UAN Codes

             0009-0000-23-009-H05-P

            Session Code

            23RW09-ABC28

            Accreditation Hours

            1.0 hours of CE

            Accreditation Statement

            The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

            Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-23-009-H05-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

            Grant Funding

            There is no grant funding for this activity.

            Faculty

            Benjamin Malcolm, PharmD., MPH
            Psychopharmacology Consultant
            Spirit Pharmacist LLC
            Eugene OR

            Faculty Disclosure

            • Benjamin Malcolm is both an owner and employee of Spirit Pharmacist LLC. He plays an advisor role in exchange for stock in the non-publicly traded company Kaivalya Kollectiv. He functions as a psychopharmacology consultant and has existing financial relationships with several retreat center organizations. He does not own any stock or company that aims to develop pharmaceutical or supplement products.

             

            Disclaimer

            The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

            Content

            Post Test Pharmacist

            Which of the following is true about harmala alkaloid inhibition of MAO?

            1. Harmalas strongly inhibit both MAO-A and MAO-B
            2. Harmalas are irreversible inhibitors of MAO-A
            3. Harmalas are reversible inhibitors of MAO-A

             

            Which of the following is/are red flags for serotonin toxicity when using psychedelics?

            1. Fever > 101F
            2. Dilated pupils
            3. Hallucination

             

            Which of the following drugs do you predict to be dangerous with MAOIs?

            1. A drug that releases serotonin
            2. A drug that increases GABA neurotransmission
            3. A drug that binds to opioid receptors

             

            A new drug named Seratanin has come to market. You research this compound and find that it works by blocking serotonin reuptake, lacks active metabolites, and has an elimination half life of ~48 hours. Which of the following do you predict?

            1. It could be dangerous with ayahuasca if not avoided for at least 10 days prior
            2. It could be dangerous with ayahuasca if not avoided at least 48 hours prior
            3. It could be dangerous with ayahuasca if not avoided at least 6 days prior

             

            Why is it difficult to analyze calls made to poison control centers concerning Ayahuasca?

            1. Poison control centers have received fewer than 100 calls since they started tracking so any assumption lacks statistical significance
            2. Poison control centers have been unable to verify contents of ayahuasca or other concurrent drugs users were taking
            3. Most of the calls come from older women, reflecting the Baby Boomers propensity to be more accepting of hallucinogens

            Arthur E. Schwarting Symposium LIVE Event – Thursday, April 24, 2025

            The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

            Arthur E. Schwarting Symposium 2025

            Information Overload: Sorting the Wheat from the Chaff

            Five hours of live CE that will include 1 hour of Law, 1 hour of Patient Safety
            Thursday, April 24, 2025
            10:30 am – 4:20 pm

            $25 for the first activity and $15 for each additional hour added.
            or
            $85 for 5 hours of live CE!

            REGISTER NOW

            2025 Schwarting Agenda

            11:00am-12:00 pm  Information overload to action: Decoding academic concepts for pharmacy preceptors
            Jennifer Luciano, PharmD, Director Office of Experiential Education, University of Connecticut School of Pharmacy, Storrs, CT

            At the end of this presentation the learner will:

            • Discuss how ACPE standards, the NAPLEX blueprint, and Entrustable Professional Activities (EPAs) guide the development of clinical competence in students, specifically in the context of patient care.
            • Describe the Pharmacist Patient Care Process (PPCP) and its key components.
            • Explain how the PPCP framework is applied in experiential education and clinical rotations.

            ACPE UAN: 0009-0000-25-026-L04-P                                     Application

            12:05-1:05 pm   Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety
            Youssef Bessada, PharmD, BCPS, BCPP, Assistant Clinical Professor,UConn School of Pharmacy, Storrs, CT

            At the end of this presentation the learner will:

            • Differentiate high-priority, practice-changing information from less relevant or conflicting data after reviewing the anticoagulation guidelines, literature and clinical updates.
            • Recognize common anticoagulation-related errors in pharmacy practice and implement strategies to minimize patient safety risks
            • Identify red flag situations in anticoagulation management that pose patient safety risks.
            • Determine the appropriate guidelines or evidence-based resources to guide clinical decision-making and referrals

            ACPE UAN: 0009-0000-25-029-L05-P             Application

            1:10-2:10 pm  Information Overload in Chronic Coronary Disease
            Michael White, PharmD, FCCP, FCP, BOT Distinguished Professor and Chair of Pharmacy Practice University of Connecticut School of Pharmacy, Storrs, CT

            At the end of this presentation the learner will:

            • Determine if a patient has chronic cardiac disease (CCD).
            • Identify lifestyle modifications that can reduce the risk of CCD.
            • Identify therapies that can reduce final health outcomes for specific CCD patient types to design successful drug regimens.
            • Describe how the steps in the PPCP process can be applied when reviewing a cardiac patient.

            ACPE UAN:  0009-0000-25-028-L01-P            Application

            2:15-3:15 pm Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination
            Caroline Wick, JD, MSPH, BA, Practitioner-in-Residence and Acting Director of the Disability Rights Law Clinic, American University Washington College of Law, Washington DC 

            At the end of this presentation the learner will:

            • Describe the federal and state laws that protect patients with disabilities
            • Recognize situations in which accommodations should be provided to disabled patients
            • Recall examples of common modifications for patients with disabilities

            ACPE UAN: 0009-0000-25-027-L03-P            Knowledge

            3:20-4:20 pm- So Much STI Data: Information to help you stay current and informed
            Jennifer Girotto, PharmD, BCPPS, BCIDP, Associate Clinical Professor, UConn School of Pharmacy, Storrs, CT

            At the end of this presentation the learner will

            • Describe updated screening recommendations and epidemiological trends of sexually transmitted infections (STIs).
            • Review the Centers for Disease Control and Prevention’s STIs recommendations.
            • Explain latest evidence based STI updates.
            • Given medication shortages, outline the pharmacist’s role in delivering targeted patient education and implementing strategies for responsible medication stewardship for STIs.

            ACPE UAN: 0009-0000-25-030-L01-P             Application

             

            Handouts will be posted 72 hours prior to the event  in 2 slide/page and 6 slide/page below:

            11:00am-12:00 pm    Information overload to action: Decoding academic concepts for pharmacy preceptors     2 slides/page
                                                     Information overload to action: Decoding academic concepts for pharmacy preceptors     6 slides/page

            12:05-1:05 pm           Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety   2 slides/page
                                                     Patient Safety: Anticoagulation Stewardship: Identifying Key Data, Avoiding Errors, and Enhancing Safety     6 slides/page

            1:10-2:10 pm         Information Overload in Chronic Coronary Disease – 2 slides/page
                                               Information Overload in Chronic Coronary Disease – 6 slides/page

            2:15-3:15 pm          Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination 2 slides/page
                                                 Law: Understanding Disabled Pharmacy Patients’ Right to Nondiscrimination 6 slides/page                 

            3:20-4:20 pm     So Much STI Data: Information to help you stay current and informed – 2 slides/page
                                            So Much STI Data: Information to help you stay current and informed – 6 slides/page

            ACPE Logo“The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.”